Kiora Pharmaceuticals Accounts Payable

Kiora Pharmaceuticals (KPRX) currently reports a accounts payable of $220K as of June 2026. That compares with $280K in the prior-year period — down 23.4% year over year. Use the charts on this page to explore Kiora Pharmaceuticals's accounts payable history and peer comparisons.

Kiora Pharmaceuticals's accounts payable decreased from $280K to $220K — a 23.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kiora Pharmaceuticals reported $220K in accounts payable as of June 2026. That compares with $280K in the prior-year period — down 23.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $220K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kiora Pharmaceuticals, and consider following KPRX for alerts when major investors trade the stock.

Kiora Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $220K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KPRX with unrelated industries.